Stemline Therapeutics Inc (NASDAQ:STML)

17.75
Delayed Data
As of Feb 23
 +0.15 / +0.85%
Today’s Change
6.35
Today|||52-Week Range
18.00
+13.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.00654.2K1.0M
 
 
 
Depreciation And Amortization76.7K153.3K153.8K80.3K
 
 
 
 
 
 
Operating ExpensesGross Income-76.7K-153.3K----
 
 
 
General Expenses24.0M29.2M38.1M39.8M
 
 
 
 
 
Research And Development16.2M21.2M29.5M27.9M
 
 
 
 
 
Total Operating Expenses24.1M29.3M38.3M39.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.1M-29.3M-37.6M-38.9M
 
 
 
 
 
Extraordinary Credit30.4K0.000.000.00
 
 
Interest Expense On Debt516.9K0.000.000.00
 
 
Other Expenses321.3K338.9K1.6K11.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.2M-28.8M-37.2M-38.3M
 
 
 
 
 
Income Taxes0.000.000.00-25.3K
 
 
Net Income-24.2M-28.8M-37.2M-38.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.3M12.9M17.3M17.8M
 
 
 
 
 
Shares To Calculate EPS Diluted10.3M12.9M17.3M17.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.35-$2.23-$2.15-$2.15
 
 
 
 
 
EPS Diluted-$2.35-$2.23-$2.15-$2.15